| Absenteeism | Presenteeism | Work productivity loss | Activity impairment |
---|
Sample size | 201 | 201 | 201 | 376 |
VAS pain score | 0.24 * | 0.54 ** | 0.49 ** | 0.59** |
PSQI | 0.23 * | 0.57 ** | 0.53 ** | 0.58** |
CES-D | 0.25 * | 0.59 ** | 0.55 ** | 0.61** |
FSS | 0.27 * | 0.61 ** | 0.56 ** | 0.66** |
BASDAI | 0.26* | 0.60 ** | 0.55 ** | 0.67** |
BASFI | 0.24 * | 0.58 ** | 0.51 ** | 0.68** |
EQ-5D | -0.25 * | -0.55 ** | -0.51 ** | -0.66 ** |
HAQ-S | 0.21 * | 0.48 ** | 0.43 ** | 0.64 ** |
ASQOL | 0.27 * | 0.63 ** | 0.57 ** | 0.69 ** |
SF-36 PCS | -0.29 * | -0.67 ** | -0.61 ** | -0.75 ** |
SF-36 MCS | -0.29 * | -0.48 ** | -0.49 ** | -0.50 ** |
- VAS, Visual Analogue Scale; PSQI, Pittsburgh Sleep Quality Index; CES-D, Center for Epidemiological Studies Depression; FSS, Fatigue Severity Scale; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; EQ-5D, EuroQol-5 Dimension questionnaire; HAQ-S, Health Assessment Questionnaire for the Spondyloarthropathies; ASQOL, Ankylosing Spondylitis Quality of Life Questionnaire; SF-36, Short-Form 36 Health Survey; PCS, physical component summary; MCS, mental component summary
- * P < 0.01
- ** P < 0.001 (Bonferroni-adjusted α-level)